Retentissement clinique des nouvelles technologies d'imagerie médicale : l'exemple de la stratégie de dépistage du cancer du sein = Clinical effects of new technologies in medical imagery : the example of breast screeningCHARAVEL, Marie; TIGAUD, Jean Dominique; CHABERT, Philippe et al.Bulletin du cancer. 2007, Vol 94, Num 11, pp 1008-1016, issn 0007-4551, 9 p.Article

A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer : results of the ERASME 3 studyCASSIER, Philippe A; CHABAUD, Sylvie; AGOSTINI, Cecile et al.Breast cancer research and treatment. 2008, Vol 109, Num 2, pp 343-350, issn 0167-6806, 8 p.Article

Neoadjuvant chemotherapy for unresectable ovarian carcinoma: A French multicenter studyANSQUER, Yan; LEBLANC, Eric; FOURME, Emmanuelle et al.Cancer. 2001, Vol 91, Num 12, pp 2329-2334, issn 0008-543X, 6 p.Article

Epirubicin and paclitaxel (EPI-TAX regimen) for advanced ovarian cancer after failure of platinum-containing regimensRAY-COQUARD, Isabelle; BACHELOT, Thomas; GUASTALLA, Jean-Paul et al.Gynecologic oncology (Print). 2003, Vol 88, Num 3, pp 351-357, issn 0090-8258, 7 p.Article